Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 38-3936533 · Snapshot of IRS recognition, filing currency, financial health, and governance.
1)provide recognition to healthcare providers and scientists who make significant contributions in the area of the diagnosis and treatment of Dyslipidemia.2)carry out research related to the management of Dyslipidemia tofurther patient care and cvd risk reduction.3)assist patients with significant or severe Dyslipidemia in thediagnosis and management of their condition in order to prevent thepremature heart disease, stroke, kidney disease, neuropathy, eyedisease, and recurrent pancreatitus that may occur with theseconditions.4)provide patients with Dyslipidemia and their healthcare providerswith education about the diagnosis and management of dyslipidemiasthrough a website, by direct mailing, or with educational programs.5)provide patients with Dyslipidemia and their healthcare providerswith information about experts on dyslipidemias in their geographicarea.
Total Revenue
$53K
FY2023
Total Expenses
$42K
FY2023
Net Assets
$10K
Program Ratio
93.2%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.